Nav: Home

Colorectal cancer risk varies based on Latino subgroup affiliation

December 14, 2015

In a first study of its kind, USC researchers have found that colorectal cancer risk in Californian Latinos vary widely depending on their country of origin.

Latinos are the largest and fastest growing minority ethnic group in America. Some 14.7 million Latinos live in California. They represent 38.4 percent of the state's population and 27 percent of the entire U.S. Latino population, according to the U.S. Census Bureau.

"Hispanics are a very heterogeneous population, which is not really recognized in most cancer studies," said Mariana Stern, lead author, a cancer epidemiologist and associate professor of preventive medicine in the Keck School of Medicine of USC. "Their risk factors might be different; their clinical characteristics could be different. We have to zoom into these observations and understand these disparities because they may affect how patients are educated about the disease and how they are treated by doctors."

The study was published online Nov. 23 in Cancer Causes & Control. USC researchers used California Cancer Registry data. They examined the profiles of 36,133 Latinos and 174,710 whites who were diagnosed with colorectal cancer between 1995 and 2011. Latinos were further identified by their country of origin: Mexico, Cuba, Puerto Rico, Central or South America, or not specified. USC researchers hope to pave the road toward personalized cancer care.

"Nowadays, most of the information we have on the molecular characteristics of colorectal cancer comes from the white population," said Stern, who is Latina. "There is little information specific to Latinos. Plus, they are typically clumped as a group."

Finding Highlights

  • Latinos from Mexico have the lowest chance of getting colorectal cancer when compared to other Latino subgroups.
  • More Mexicans (20 percent) and Central or South Americans (20 percent) were diagnosed with colorectal cancer before age 50 compared to other Latino subgroups.
  • Among Latinos in California, Cuban colorectal cancer patients had the highest proportion of deaths (63 percent), followed by Puerto Ricans (58 percent).
  • Mexicans had a higher percentage of rectal cancer (35 percent) than other Latino subgroups.
Study Significance

"We have pioneered surveillance of ethnic differences in cancer risk," said Lihua Liu, senior author, assistant professor of clinical preventive medicine at Keck Medicine of USC and a research scientist in the Los Angeles Cancer Surveillance Program. "We have previously shown dramatic differences in cancer risk among Asian subgroups. It's time to also examine the heterogeneity within Latinos."

However, hospitals and clinics in California do not have a standardized practice for collecting detailed ethnic and birthplace information, which resulted in a large proportion of Latino patients without country of origin information, posing a notable weakness of the study.

Standardizing ethnic and birthplace data collection will help guide future cancer control strategies, Liu said. The objective is to reduce the impact of cancer, the leading cause of death in the Latino community. In contrast, the No. 1 cause of death among whites is heart disease, followed by cancer.

Genetics, varying degrees of inter-mixing as well as acculturation to the U.S. lifestyle could all influence colorectal cancer incidence rates. For example, Latinos from the Caribbean generally have more African and fewer indigenous American forefathers. People from Mexico, however, have a larger proportion of indigenous American ancestry than Puerto Ricans or Cubans, Stern said.

"Maybe the biology of people from Mexico protects them from developing colorectal cancer," she added. "This has been reported for breast cancer too. The heterogeneity of Latino populations presents a unique opportunity to disentangle the complex role of socio-demographics, culture, lifestyle and genetics as potential determinants of colorectal cancer risk among Latinos and other populations."
-end-


University of Southern California

Related Cancer Articles:

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.
Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.
Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.
Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.
More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.
New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.
American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.
Oncotarget: Cancer pioneer employs physics to approach cancer in last research article
In the cover article of Tuesday's issue of Oncotarget, James Frost, MD, PhD, Kenneth Pienta, MD, and the late Donald Coffey, Ph.D., use a theory of physical and biophysical symmetry to derive a new conceptualization of cancer.
Health indicators for newborns of breast cancer survivors may vary by cancer type
In a study published in the International Journal of Cancer, researchers from the UNC Lineberger Comprehensive Cancer Center analyzed health indicators for children born to young breast cancer survivors in North Carolina.
Few women with history of breast cancer and ovarian cancer take a recommended genetic test
More than 80 percent of women living with a history of breast or ovarian cancer at high-risk of having a gene mutation have never taken the test that can detect it.
More Cancer News and Cancer Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Teaching For Better Humans 2.0
More than test scores or good grades–what do kids need for the future? This hour, TED speakers explore how to help children grow into better humans, both during and after this time of crisis. Guests include educators Richard Culatta and Liz Kleinrock, psychologist Thomas Curran, and writer Jacqueline Woodson.
Now Playing: Science for the People

#556 The Power of Friendship
It's 2020 and times are tough. Maybe some of us are learning about social distancing the hard way. Maybe we just are all a little anxious. No matter what, we could probably use a friend. But what is a friend, exactly? And why do we need them so much? This week host Bethany Brookshire speaks with Lydia Denworth, author of the new book "Friendship: The Evolution, Biology, and Extraordinary Power of Life's Fundamental Bond". This episode is hosted by Bethany Brookshire, science writer from Science News.
Now Playing: Radiolab

Dispatch 3: Shared Immunity
More than a million people have caught Covid-19, and tens of thousands have died. But thousands more have survived and recovered. A week or so ago (aka, what feels like ten years in corona time) producer Molly Webster learned that many of those survivors possess a kind of superpower: antibodies trained to fight the virus. Not only that, they might be able to pass this power on to the people who are sick with corona, and still in the fight. Today we have the story of an experimental treatment that's popping up all over the country: convalescent plasma transfusion, a century-old procedure that some say may become one of our best weapons against this devastating, new disease.   If you have recovered from Covid-19 and want to donate plasma, national and local donation registries are gearing up to collect blood.  To sign up with the American Red Cross, a national organization that works in local communities, head here.  To find out more about the The National COVID-19 Convalescent Plasma Project, which we spoke about in our episode, including information on clinical trials or plasma donation projects in your community, go here.  And if you are in the greater New York City area, and want to donate convalescent plasma, head over to the New York Blood Center to sign up. Or, register with specific NYC hospitals here.   If you are sick with Covid-19, and are interested in participating in a clinical trial, or are looking for a plasma donor match, check in with your local hospital, university, or blood center for more; you can also find more information on trials at The National COVID-19 Convalescent Plasma Project. And lastly, Tatiana Prowell's tweet that tipped us off is here. This episode was reported by Molly Webster and produced by Pat Walters. Special thanks to Drs. Evan Bloch and Tim Byun, as well as the Albert Einstein College of Medicine.  Support Radiolab today at Radiolab.org/donate.